[go: up one dir, main page]

BR9706369A - Processo para tratamento de unhas humanas. - Google Patents

Processo para tratamento de unhas humanas.

Info

Publication number
BR9706369A
BR9706369A BR9706369-0A BR9706369A BR9706369A BR 9706369 A BR9706369 A BR 9706369A BR 9706369 A BR9706369 A BR 9706369A BR 9706369 A BR9706369 A BR 9706369A
Authority
BR
Brazil
Prior art keywords
human nails
nails
treatment
improving
hands
Prior art date
Application number
BR9706369-0A
Other languages
English (en)
Inventor
Debra A Park
Original Assignee
Dial Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dial Corp filed Critical Dial Corp
Publication of BR9706369A publication Critical patent/BR9706369A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção para ''PROCESSO PARA TRATAMENTO DE UNHAS HUMANAS". Um processo para aperfeiçoamento da fisiologia de unhas humanas, e, mais particularmente, a um processo para aperfeiçoamento da flexibilidade de unhas é revelado. O processo involve lavagem das mãos com uma composição de limpeza, ou na forma liquida ou na forma sólida, contendo pantenol, e seguido pelo enxaguamento das mãos com água.
BR9706369-0A 1996-12-18 1997-12-17 Processo para tratamento de unhas humanas. BR9706369A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3311896P 1996-12-18 1996-12-18

Publications (1)

Publication Number Publication Date
BR9706369A true BR9706369A (pt) 1999-12-07

Family

ID=21868661

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9706369-0A BR9706369A (pt) 1996-12-18 1997-12-17 Processo para tratamento de unhas humanas.

Country Status (5)

Country Link
US (1) US6017517A (pt)
AR (1) AR010790A1 (pt)
BR (1) BR9706369A (pt)
GT (1) GT199700134A (pt)
WO (1) WO1998026761A1 (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002231736A1 (en) 2000-12-22 2002-07-08 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Use of repulsive guidance molecule (rgm) and its modulators
US6800295B2 (en) * 2002-10-09 2004-10-05 The Dial Corporation Water soluble sheet composition
US20070198196A1 (en) * 2004-08-24 2007-08-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods relating to ameliorating an immune system
CA2624562A1 (en) * 2005-09-30 2007-04-12 Abbott Gmbh & Co. Kg Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use
EP2033971A1 (de) * 2007-09-06 2009-03-11 Abbott GmbH & Co. KG Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung
US8962803B2 (en) * 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
US9175075B2 (en) 2009-12-08 2015-11-03 AbbVie Deutschland GmbH & Co. KG Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein
AU2012352168C1 (en) 2011-12-14 2018-01-25 AbbVie Deutschland GmbH & Co. KG Composition and method for the diagnosis and treatment of iron-related disorders
MX356933B (es) 2011-12-14 2018-06-20 Abbvie Deutschland Composicion y metodo para el diagnostico y tratamiento de trastornos relacionados con hierro.
AU2013211939C1 (en) 2012-01-27 2018-06-07 AbbVie Deutschland GmbH & Co. KG Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
US9469686B2 (en) 2013-03-15 2016-10-18 Abbott Laboratories Anti-GP73 monoclonal antibodies and methods of obtaining the same
WO2014197885A2 (en) 2013-06-07 2014-12-11 Duke University Inhibitors of complement factor h
CA3036717A1 (en) 2016-10-03 2018-04-12 Abbott Laboratories Improved methods of assessing gfap status in patient samples
JP7346300B2 (ja) 2017-03-23 2023-09-19 アボット・ラボラトリーズ 早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼｌ１を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法
BR112019021612A2 (pt) 2017-04-15 2020-05-12 Abbott Laboratories Métodos para auxiliar o diagnóstico hiperagudo e determinação de traumatismo crânioencefálico em um indivíduo humano com o uso de biomarcadores precoces
AU2018256845B2 (en) 2017-04-28 2024-03-14 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
US10865238B1 (en) 2017-05-05 2020-12-15 Duke University Complement factor H antibodies
CA3078725A1 (en) 2017-05-25 2018-11-29 Abbott Laboratories Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
WO2018222784A1 (en) 2017-05-30 2018-12-06 Abbott Laboratories Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i
CA3068041C (en) 2017-07-03 2024-06-25 Abbott Laboratories Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
EP3721233A2 (en) 2017-12-09 2020-10-14 Abbott Laboratories Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (tbi), using glial fibrillary acidic protein (gfap) and/or ubiquitin carboxy-terminal hydrolase l1 (uch-l1)
CA3067055A1 (en) 2017-12-09 2019-06-13 Abbott Laboratories Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
EP4136459A1 (en) 2020-04-13 2023-02-22 Abbott Laboratories Methods, complexes and kits for detecting or determining an amount of a ss-coronavirus antibody in a sample
CA3177830A1 (en) 2020-05-13 2021-11-18 Maria BECONI Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis
WO2022031804A1 (en) 2020-08-04 2022-02-10 Abbott Laboratories Improved methods and kits for detecting sars-cov-2 protein in a sample
JP2023536737A (ja) 2020-08-04 2023-08-29 アボット・ラピッド・ダイアグノスティクス・インターナショナル・アンリミテッド・カンパニー Ｓａｒｓ－ｃｏｖ－２を検出するためのアッセイ
WO2023102384A1 (en) 2021-11-30 2023-06-08 Abbott Laboratories Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
WO2022119841A1 (en) 2020-12-01 2022-06-09 Abbott Laboratories Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
WO2022147147A1 (en) 2020-12-30 2022-07-07 Abbott Laboratories Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
AU2022279156A1 (en) 2021-05-18 2023-11-02 Abbott Laboratories Methods of evaluating brain injury in a pediatric subject
EP4356129A1 (en) 2021-06-14 2024-04-24 Abbott Laboratories Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
AU2022339759A1 (en) 2021-08-31 2024-03-07 Abbott Laboratories Methods and systems of diagnosing brain injury
CN118715440A (zh) 2021-08-31 2024-09-27 雅培实验室 诊断脑损伤的方法和系统
EP4409294A1 (en) 2021-09-30 2024-08-07 Abbott Laboratories Methods and systems of diagnosing brain injury
AU2022413677A1 (en) 2021-12-17 2024-06-27 Abbott Laboratories Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
CN119256227A (zh) 2022-02-04 2025-01-03 雅培实验室 用于检测样品中泛素羧基末端水解酶l1和/或胶质纤维酸性蛋白的存在或测量其量的侧向流方法、测定和装置
WO2024006876A1 (en) 2022-06-29 2024-01-04 Abbott Laboratories Magnetic point-of-care systems and assays for determining gfap in biological samples
CA3265992A1 (en) 2022-09-15 2024-03-21 Abbott Laboratories BIOMARKERS AND METHODS FOR DIFFERENTIATING BETWEEN MILD AND VERY MILD TRAUMATIC BRAIN INJURY
WO2024211475A1 (en) 2023-04-04 2024-10-10 Abbott Laboratories Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
WO2024226971A1 (en) 2023-04-28 2024-10-31 Abbott Point Of Care Inc. Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33845A (en) * 1861-12-03 Improvement in harvesting-machines
US3034965A (en) * 1958-06-12 1962-05-15 Rose P Drake Composition and method for treating nails
GB1514469A (en) * 1974-08-01 1978-06-14 Beecham Group Ltd Oral hygiene compositions
US4158053A (en) * 1977-08-05 1979-06-12 Eli Lilly And Company Aqueous emulsion polymer nail coating formulations
US4402935A (en) * 1981-04-16 1983-09-06 Del Laboratories, Inc. Moisturizing nail polish composition
US4416873A (en) * 1982-06-01 1983-11-22 Charles Of The Ritz Group Ltd. Combined allantoin-hydrolyzed animal protein skin preparation
US4478853A (en) * 1982-05-17 1984-10-23 S. C. Johnson & Son, Inc. Skin conditioning composition
US4970220A (en) * 1982-05-17 1990-11-13 S. C. Johnson & Son, Inc. Skin conditioning composition
US4534964A (en) * 1982-10-04 1985-08-13 Richardson-Vicks Inc. Hair conditioning shampoo
US4863725A (en) * 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4851434A (en) * 1983-05-27 1989-07-25 Deckner George E Novel non-irritating moisturizer, compositions containing same and method
US4482537A (en) * 1983-09-19 1984-11-13 Charles Of The Ritz Group Ltd. Skin conditioning composition
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
US4595586A (en) * 1985-08-30 1986-06-17 Eli Lilly And Company Moisturizing lotion
JPS62111909A (ja) * 1985-11-09 1987-05-22 Shiseido Co Ltd 美爪料
US4690818A (en) * 1986-02-03 1987-09-01 Charles Of The Ritz Group Ltd. Shampoo and bath and shower gel
NL8601767A (nl) 1986-07-07 1988-02-01 Schreuder Chem Adviesbureau Huidbruiningsmiddel.
US4832872A (en) * 1988-01-22 1989-05-23 Richardson-Vicks Inc. Hair conditioning shampoo
US4857321A (en) * 1988-08-26 1989-08-15 Thomas William C Skin ointment
US5069898A (en) * 1989-04-24 1991-12-03 Revlon, Inc. Hair enrichment composition and method of use
US5041285A (en) * 1990-01-29 1991-08-20 Larry D. Lundmark Method of treating the hair with an allanoyoin-panthenol product
US5102654A (en) * 1990-04-18 1992-04-07 Revlon, Inc. Nail enamel emulsion lacquer comprising a water phase and a lacquer phase
US5136093A (en) * 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
AU3136593A (en) * 1991-11-22 1993-06-15 Richardson-Vicks Inc. Combined personal cleansing and moisturizing compositions
US5425954A (en) * 1993-09-30 1995-06-20 Curafas Incorporated Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use
CN1159159A (zh) * 1994-08-26 1997-09-10 普罗克特和甘保尔公司 个人清洁用组合物
US5445823A (en) * 1994-10-20 1995-08-29 The Procter & Gamble Company Dermatological compositions and method of treatment of skin lesions therewith

Also Published As

Publication number Publication date
GT199700134A (es) 1999-06-05
US6017517A (en) 2000-01-25
AR010790A1 (es) 2000-07-12
WO1998026761A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
BR9706369A (pt) Processo para tratamento de unhas humanas.
ATE279922T1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
FI932200A0 (fi) Foer hudrengoering avsedd mild toalettbit, som innehaoller foer huden milt/fuktgivande silikonhjaelpmedel
BR8904828A (pt) Processo para preparacao de emulsoes de limpeza para tratamento de beleza,respectivas emulsoes e espumas de banho,locoes de limpeza,oleos de banho e sabonetes liquidos
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
BR0111399A (pt) Regeneração de artigo de tecido em processos integrados de tratamento e limpeza
DE69618787D1 (de) Topische zusammensetzungen mit verbessertem hautgefühl
PT1056856E (pt) Factor neurotrofico cliliar modificado processo de preparacao e sua utilizacao
DK0792144T3 (da) Rengøringsvæv behandlet med vand-i-lipid emulsion
ATE81978T1 (de) Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
BR9802120A (pt) Composição cosmética e/ou dermatológica composição dermatologica processo de tratamento cosmético utilização de uma composição processo de conservação de composições e utilização de um polímero poliaminado
DE3888904D1 (de) Hautreinigungsstück mit niedrigem Feuchtegehalt.
BR9302858A (pt) Composicao para a higiene pessoal,barra para limpeza da pele suave,composicao de shampoo suave,sabao liquido suavel,gel para banho suave,e,processo para a higiene corporal
DE69008342D1 (de) Orthese für die Behandlung von Schienbeinverdrehungen bei Kindern.
BR8603961A (pt) Composicao detergente para tratamento de tecidos;composicao detergente encorpada,nao aquosa para lavagem de roupas pesadas e composicao liquida e processo para limpar tecidos sujos
DE69429160D1 (de) Behandlung von textilprodukt
BR9609602A (pt) Composição cosmética anidra utilização da composição e processo de tratamento cosmético
DE69617963D1 (de) Behandlung von titandioxidaufachlämmungen mittels scherkräften
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
FI971127L (fi) 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen
BR9300651A (pt) Processo para determinar a presenca e/ou concentracao de um polimero para tratamento de agua em uma amostra aquosa,hibridoma e composicao
SE9100480L (sv) Rengoeringsprodukt
PH31608A (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses.
BR8902113A (pt) Composicao detergente liquida,aquosa,isotropica,e processo para tratar tecidos
DE59002772D1 (de) Verwendung von Dextransulfat, gegebenenfalls in Kombination mit anti-androgenen Mitteln zur Behandlung des humanen Protatakarzinoms.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1849 DE 13/06/2006.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 3/00 (2006.01), A61K 8/42 (2006.0